pharmaceutical composition, sealed container, metered dose inhaler, method for treating a patient suffering or likely to suffer from a respiratory disorder, and methods for stabilizing a pharmaceutical composition, to increase the settling time of a pharmaceutical composition and to improve aerosolization performance?

摘要

It is a pharmaceutical composition. the composition comprises at least one mometasone compound selected from mometasone, pharmaceutically acceptable salts of mometasone, mometasone prodrugs, mometasone solvates, pharmaceutically acceptable salts of mometasone and mometasone prodrug solvates and a propellant component comprising 1,1-difluoroethane (r-152a). in a preferred embodiment, the composition further comprises at least one formoterol compound selected from formoterol, pharmaceutically acceptable salts of formoterol, formoterol prodrugs, formoterol solvates, pharmaceutically acceptable salt solvates of formoterol and formoterol prodrug solvates .